s 14297 has been researched along with haloperidol in 2 studies
Studies (s 14297) | Trials (s 14297) | Recent Studies (post-2010) (s 14297) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
15 | 0 | 0 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X | 1 |
Brocco, M; Gressier, H; Millan, MJ | 1 |
2 other study(ies) available for s 14297 and haloperidol
Article | Year |
---|---|
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water | 2003 |
The dopamine D3 receptor antagonist, (+)-S 14297, blocks the cataleptic properties of haloperidol in rats.
Topics: 2-Naphthylamine; Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Furans; Haloperidol; Male; Rats; Rats, Wistar; Receptors, Dopamine D3; Stereoisomerism | 1997 |